-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Elevance Health, Lowers Price Target to $500

Benzinga·06/09/2025 17:27:50
Listen to the news
Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $510 to $500.